A Study of TD-9855 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)
Public ClinicalTrials.gov record NCT01458340. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2 Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Proof-of-Concept Study of TD-9855 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The safety and efficacy of multiple dosages of TD-9855, administered once daily, will be evaluated in adult males with ADHD.
Study identification
- NCT ID
- NCT01458340
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 295 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 45 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 2011 (Actual)
- Primary completion
- Oct 2013 (Actual)
- Completion
- Nov 2013 (Actual)
- Last update posted
- Apr 4, 2022
2011 – 2013
United States locations
- U.S. sites
- 17
- U.S. states
- 13
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Florida Clinical Research Center, LLC | Bradenton | Florida | 34201 | — |
| Clinical Neuroscience Solutions, Inc. | Jacksonville | Florida | 32256 | — |
| Florida Clinical Research Center | Maitland | Florida | 34201 | — |
| Janus Ctr. for Psychiatric Research | Palm Beach | Florida | 33407 | — |
| Carman Research | Smyrna | Georgia | 30080 | — |
| Psychiatric Associates | Overland Park | Kansas | 66211 | — |
| Midwest Research Group | Saint Charles | Missouri | 63304 | — |
| Ctr. for Psychiatry & Behavioral Med. | Las Vegas | Nevada | 89128 | — |
| Adult ADHD Program | New York | New York | 10016 | — |
| IPS Research | Oklahoma City | Oklahoma | 73103 | — |
| Summit Research Network | Portland | Oregon | 97210 | — |
| Lincoln Research | Lincoln | Rhode Island | 02865 | — |
| CNS Healthcare of Memphis | Memphis | Tennessee | 38119 | — |
| FutureSearch Clinical Trials | Austin | Texas | 78731 | — |
| Psychiatric & Behavioral Solutions | Salt Lake City | Utah | 84105 | — |
| Lifetree Clinical Research, LC | Salt Lake City | Utah | 84106 | — |
| Summit Research Network (Seattle), LLC | Seattle | Washington | 98104 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01458340, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 4, 2022 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01458340 live on ClinicalTrials.gov.